The industry’s top-selling drugs generate billions in revenues each year. Scrip analyzed data on nearly 200 blockbuster drugs to see...      Related Stories The Life Of A Blockbuster Hypertension To Mental Health Drugs: Indian Firms Supplied Bulk Of Rx Volume In US Test publish Article   ..read more

Public Company Edition: Verona Pharma arranged up to $400m in new debt and up to $250m in revenue-related financing ahead...      Related Stories Sanofi’s $500m COVID-19 Deal Comes Four Years Too Late MacroGenics Plunges On Prostate Cancer ADC Safety Concerns Pipeline Watch: Five Approvals And 13 Phase III Readouts   ..read more

Months after an antitrust lawsuit challenged its deal with Sanofi and raised uncertainty about the future of MZE001, Maze secured...      Related Stories Takeda Tightens Belt As It Anticipates Difficult 2024, With Growth Returning After Lupin CEO Highlights Structural Support For Generics Pricing, Sees gMyrbetriq Relaunch Vaccine Star's Surprise Downfall Indicative Of Trouble In China’s COVID Push?   ..read more

But it rescues embattled Novavax.          Related Stories MacroGenics Plunges On Prostate Cancer ADC Safety Concerns Pipeline Watch: Five Approvals And 13 Phase III Readouts Gene Therapy Q1 Roundup: The Struggle Is Real   ..read more

A more than 70% stock slide shows that investors are concerned about three as-yet unexplained deaths in a Phase II...      Related Stories Sanofi’s $500m COVID-19 Deal Comes Four Years Too Late Pipeline Watch: Five Approvals And 13 Phase III Readouts Gene Therapy Q1 Roundup: The Struggle Is Real   ..read more

The drug maker has its eye on six Phase III or Phase III-ready programs that it hopes will return the...      Related Stories Takeda Tightens Belt As It Anticipates Difficult 2024, With Growth Returning After Lupin CEO Highlights Structural Support For Generics Pricing, Sees gMyrbetriq Relaunch Vaccine Star's Surprise Downfall Indicative Of Trouble In China’s COVID Push?   ..read more

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies...      Related Stories Pipeline Watch: Five Approvals And 13 Phase III Readouts Gene Therapy Q1 Roundup: The Struggle Is Real Regeneron Gene Therapy Reaches New Heights In Restoring Hearing   ..read more

Lupin’s CEO spoke of US drug shortages having led to recognition of the need for structural and regulatory support for...      Related Stories Vaccine Star's Surprise Downfall Indicative Of Trouble In China’s COVID Push? Finance Watch: Clinical-Stage Autoimmune Start-Ups Garner Big Investments Takeda Tightens Belt As It Anticipates Difficult 2024, With Growth Returning After   ..read more

Apparently months after his actual detention, news has finally surfaced that a key researcher behind China's rapid development of a...      Related Stories Finance Watch: Clinical-Stage Autoimmune Start-Ups Garner Big Investments Takeda Tightens Belt As It Anticipates Difficult 2024, With Growth Returning After Astellas Rejigs R&D Focus Areas As It Withdraws From Mitochondria R&D   ..read more

Private Company Edition: Attovia will advance two anti-IL-31 programs with its $105m in series B funding, while ImmuNext secured $575m...      Related Stories Takeda Tightens Belt As It Anticipates Difficult 2024, With Growth Returning After Astellas Rejigs R&D Focus Areas As It Withdraws From Mitochondria R&D Chinese Drug Makers Trim, Boost Pipelines In New R&D Drive   ..read more